Nabi Biopharmaceuticals (PentaStaph vaccine program) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Nabi Biopharmaceuticals (PentaStaph vaccine program) General Information

Description

A license for developing vaccine in Rockville, Maryland. The licence features development rights of a vaccine namely, PentaStaph, to be used against staphylococcal infections.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
GlaxoSmithKline
Primary Office
  • 12270 Wilkins Avenue
  • Rockville, MD 20852
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nabi Biopharmaceuticals (PentaStaph vaccine program) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nabi Biopharmaceuticals (PentaStaph vaccine program)‘s full profile, request access.

Request a free trial

Nabi Biopharmaceuticals (PentaStaph vaccine program) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nabi Biopharmaceuticals (PentaStaph vaccine program)‘s full profile, request access.

Request a free trial